Everence Capital Management Inc Lantheus Holdings, Inc. Transaction History

Everence Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	BUY	$61.42 - $86.29 $105,642 - $148,418	1,720 Added 14.22%	13,813 $971,000
Q2 2022 Jul 26, 2022	SELL	$55.54 - $72.65 $123,298 - $161,283	-2,220 Reduced 15.51%	12,093 $799,000
Q1 2022 Apr 11, 2022	BUY	$24.28 - $56.64 $88,622 - $206,736	3,650 Added 34.23%	14,313 $792,000
Q3 2021 Oct 21, 2021	BUY	$24.23 - $28.59 $242 - $285	10 Added 0.09%	10,663 $274,000
Q3 2020 Feb 01, 2021	BUY	$11.98 - $16.34 $127,622 - $174,070	10,653 New	10,653 $135,000

540

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.22B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.